Pricing Log in Create free account

Incannex Healthcare Inc. (IXHL) vs Universe Pharmaceuticals INC (UPC)

Incannex Healthcare Inc. and Universe Pharmaceuticals INC are both Drug Manufacturers Specialty & Generic companies. Incannex Healthcare Inc. is the larger, with a market value of $36.1M against $20.9M — 1.7× the size. Incannex Healthcare Inc. has the higher net margin (0.00% vs −6.42%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Universe Pharmaceuticals INC leads on 7 and Incannex Healthcare Inc. on 6.

Valuation

Metric IXHL UPC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 21.06 n/m 2.11
P/B 0.49 n/m 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA 1.36 8.52 12.58
EV/Sales (19.90) (0.24) 2.73
Earnings yield (60.71%) (36.78%) (4.38%)
Free cash flow yield (39.17%) 0.00% 0.00%

Profitability

Metric IXHL UPC Drug Manufacturers Specialty & Generic median
Gross margin (0.10%) 49.77% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (6.42%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (47.80%) 0.00% (0.40%)
Return on assets (41.32%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IXHL UPC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 10.01%
EPS growth (last fiscal year) 95.91% 98.71% 49.06%
Revenue growth, 5-year CAGR (29.64%) (10.27%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IXHL UPC Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.17 0.05
Current ratio 48.81 4.05 2.31
Net debt to EBITDA 2.97 10.15 0.97

Dividend

Metric IXHL UPC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric IXHL UPC Drug Manufacturers Specialty & Generic median
Market cap 36.12m 20.85m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack